FDA will allow ZYN Nicotine pouches to stay on market

FDA makes key decision on Zyn nicotine pouches
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches. The pouches, which are placed between the lip and gum, are tobacco-free but contain nicotine. They come in different strengths and a variety of flavors such as citrus, coffee, peppermint and berry.
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokers
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes.
Zyn nicotine pouches can be marketed in the U.S., the FDA says. What does this mean?
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious health conditions compared to cigarettes and smokeless tobacco products.
FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes
The FDA authorized the marketing of 20 Zyn products on Thursday, marking the first allowance for the fast-growing nicotine pouches.
FDA officially authorizes Zyn nicotine pouches for sale following health review
The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive scientific review" about their safety.
Zyn nicotine pouches get FDA approval
FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products' appeal to teens.
Zyn’s Flavored Nicotine Pouches Win Marketing Approval From FDA
The US Food and Drug Administration approved the marketing of 20 Zyn products to adults, the first time it has authorized nicotine pouches.
US FDA grants first market authorization of nicotine pouches to Zyn
The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, the first such authorization for nicotine pouches in the country. The authorized products pose lower risk of cancer and other serious health conditions than cigarettes and most smokeless tobacco products,
Philip Morris Gains Competitive Edge with FDA Authorization of ZYN Nicotine Pouches
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of
Nicotine pouches get FDA approval, with some calling them Gen Z's favorite weight loss hack
Little pouches of nicotine sold by the brand ZYN were given the green light for marketing this week through the U.S. Food and Drug Administration’s premarket tobacco product application (PMTA) pathway.
Let Freedom Zyn
Let freedom ryng: On Thursday, the Food and Drug Administration (FDA) authorized the marketing of 20 Zyn nicotine pouch ...
Need for Balancing Youth Protection and Adult Access: The Imperative of FDA's Zyn Authorization
The U.S. Food and Drug Administration's authorization of 20 Zyn nicotine pouch products addresses an ongoing need to provide ...